Pub Date : 2026-01-19DOI: 10.1186/s12986-025-01065-1
Yunhang Chu, Ming Yang, Qi Meng, Delong Cong, Lingyu Xu, Peng Dai, Ziqiang Chen, Sulan Chen, Rui Zhang, Yan Leng
<p><strong>Objective: </strong>Systematic evaluation of the efficacy and safety of lower-carbohydrate dietary patterns (LCDP) in metabolic associated fatty liver disease (MAFLD).</p><p><strong>Methods: </strong>The literature search was conducted in 8 databases, covering all relevant randomized controlled trials on LCDP intervention for MAFLD patients from the database establishment to June 1, 2025. The quality of the literature was evaluated using the Cochrane Bias Risk Assessment Tool. The extracted data were analyzed using Review Manager 5.3 software for meta-analysis. Sensitivity analysis and publication bias detection were performed using Stata 18.0 software.</p><p><strong>Results: </strong>The study included 9 randomized controlled trials (RCTs) that met the criteria, involving 408 MAFLD patients and covering 18 outcome measures related to anthropometry, liver function, blood pressure, blood lipids, and blood glucose. The study results indicate that LCDP can significantly affect the body weight (BW) and its 95% confidence intervals (CI) is -4.09 kg[-7.36, -0.81]; waist circumference (WC) -4.84 cm[-5.46, -4.23]; body mass index (BMI) -1.60 kg/m<sup>2</sup>[-2.41, -0.79]; diastolic blood pressure (DBP) -3.47mmHg[-5.23, -1.71]; triglycerides (TG) -0.45mmol/L[-0.73, -0.17]; fasting plasma glucose (FPG) -0.33mmol/L[-0.60, -0.06] and homeostatic model assessment of insulin resistance (HOMA-IR) -1.57[-2.52, -0.62] levels in patients with MAFLD. Subgroup analysis based on dietary subtypes showed that low carbohydrate diets (LCD) significantly affect the alanine aminotransferase (ALT) -6.82U/L[-12.15, -1.49] levels in MAFLD patients. Very low carbohydrate, high-fat ketogenic diets (VLCKD) can significantly affect the BW -4.62 kg[-8.10, -1.14]; WC -4.90 cm[-5.53, -4.28]; waist-to-hip ratio (WHR) -0.03[-0.05, -0.01]; BMI - 1.68 kg/m<sup>2</sup>[-2.64, -0.71]; TG -0.56mmol/L[-0.87, -0.24]; glycated hemoglobin (HbAlc) -0.61%[-1.13, -0.09] and HOMA-IR -2.27[-4.01, -0.54] in MAFLD patients. When the LCDP intervention cycle is 8 weeks, it may had no significant effect in MAFLD patients. When the intervention period is 12 weeks, it can significantly affect the BW -6.03 kg[-8.99, -3.07]; WC -4.88 cm[-5.50, -4.26]; BMI - 2.33 kg/m<sup>2</sup>[-2.61, -2.06]; HOMA-IR -1.44[-2.35, -0.52]; HbA1c -0.61%[-1.13, -0.09]; TG -0.50mmol/L[-0.98, -0.02]; aspartate transaminase (AST) -6.19U/L[-8.85, -3.54] and ALT - 17.09U/L[-26.40, -7.78] in MAFLD patients, and significantly affect the low-density lipoprotein cholesterol (LDL-C) + 0.22mmol/L[0.17, 0.27] in MAFLD patients. Adverse events were reported in 1 trial, commonly including dyspepsia, nausea, and found diet difficult to implement, etc. Although there is some heterogeneity in the study, the results are stable and there is no clear evidence of small-study effects.</p><p><strong>Conclusion: </strong>LCDP can improve obesity and insulin resistance (IR) in MAFLD patients, and has a layered mechanism for regulating bloo
{"title":"Efficacy and safety of lower-carbohydrate dietary patterns for metabolic associated fatty liver disease: evidence from randomized controlled trials with grade analysis.","authors":"Yunhang Chu, Ming Yang, Qi Meng, Delong Cong, Lingyu Xu, Peng Dai, Ziqiang Chen, Sulan Chen, Rui Zhang, Yan Leng","doi":"10.1186/s12986-025-01065-1","DOIUrl":"10.1186/s12986-025-01065-1","url":null,"abstract":"<p><strong>Objective: </strong>Systematic evaluation of the efficacy and safety of lower-carbohydrate dietary patterns (LCDP) in metabolic associated fatty liver disease (MAFLD).</p><p><strong>Methods: </strong>The literature search was conducted in 8 databases, covering all relevant randomized controlled trials on LCDP intervention for MAFLD patients from the database establishment to June 1, 2025. The quality of the literature was evaluated using the Cochrane Bias Risk Assessment Tool. The extracted data were analyzed using Review Manager 5.3 software for meta-analysis. Sensitivity analysis and publication bias detection were performed using Stata 18.0 software.</p><p><strong>Results: </strong>The study included 9 randomized controlled trials (RCTs) that met the criteria, involving 408 MAFLD patients and covering 18 outcome measures related to anthropometry, liver function, blood pressure, blood lipids, and blood glucose. The study results indicate that LCDP can significantly affect the body weight (BW) and its 95% confidence intervals (CI) is -4.09 kg[-7.36, -0.81]; waist circumference (WC) -4.84 cm[-5.46, -4.23]; body mass index (BMI) -1.60 kg/m<sup>2</sup>[-2.41, -0.79]; diastolic blood pressure (DBP) -3.47mmHg[-5.23, -1.71]; triglycerides (TG) -0.45mmol/L[-0.73, -0.17]; fasting plasma glucose (FPG) -0.33mmol/L[-0.60, -0.06] and homeostatic model assessment of insulin resistance (HOMA-IR) -1.57[-2.52, -0.62] levels in patients with MAFLD. Subgroup analysis based on dietary subtypes showed that low carbohydrate diets (LCD) significantly affect the alanine aminotransferase (ALT) -6.82U/L[-12.15, -1.49] levels in MAFLD patients. Very low carbohydrate, high-fat ketogenic diets (VLCKD) can significantly affect the BW -4.62 kg[-8.10, -1.14]; WC -4.90 cm[-5.53, -4.28]; waist-to-hip ratio (WHR) -0.03[-0.05, -0.01]; BMI - 1.68 kg/m<sup>2</sup>[-2.64, -0.71]; TG -0.56mmol/L[-0.87, -0.24]; glycated hemoglobin (HbAlc) -0.61%[-1.13, -0.09] and HOMA-IR -2.27[-4.01, -0.54] in MAFLD patients. When the LCDP intervention cycle is 8 weeks, it may had no significant effect in MAFLD patients. When the intervention period is 12 weeks, it can significantly affect the BW -6.03 kg[-8.99, -3.07]; WC -4.88 cm[-5.50, -4.26]; BMI - 2.33 kg/m<sup>2</sup>[-2.61, -2.06]; HOMA-IR -1.44[-2.35, -0.52]; HbA1c -0.61%[-1.13, -0.09]; TG -0.50mmol/L[-0.98, -0.02]; aspartate transaminase (AST) -6.19U/L[-8.85, -3.54] and ALT - 17.09U/L[-26.40, -7.78] in MAFLD patients, and significantly affect the low-density lipoprotein cholesterol (LDL-C) + 0.22mmol/L[0.17, 0.27] in MAFLD patients. Adverse events were reported in 1 trial, commonly including dyspepsia, nausea, and found diet difficult to implement, etc. Although there is some heterogeneity in the study, the results are stable and there is no clear evidence of small-study effects.</p><p><strong>Conclusion: </strong>LCDP can improve obesity and insulin resistance (IR) in MAFLD patients, and has a layered mechanism for regulating bloo","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":"23 1","pages":"10"},"PeriodicalIF":4.1,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12817522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146003783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-17DOI: 10.1186/s12986-026-01084-6
Yuwei Wang
{"title":"Mendelian randomization identifies causal effects of phospholipids on portal vein thrombosis risk: FADS1/2-mediated pathways and their potential as diagnostic biomarkers.","authors":"Yuwei Wang","doi":"10.1186/s12986-026-01084-6","DOIUrl":"https://doi.org/10.1186/s12986-026-01084-6","url":null,"abstract":"","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145994522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-16DOI: 10.1186/s12986-026-01080-w
Aroosa Sultan, Muhammad Nadeem Akhtar, Anees Ahmed Khalil, Faiza Jameel, Suhas Ballal, Abhayveer Singh, Rajashree Panigrahi, Abhishek Sharma, Huda Ateeq, Areesha Ahmed, Fakhar Islam, Muhammad Afzaal, Catherine Tamale Ndagire
Background: Helicobacter pylori infection and oxidative stress are most common factors for development of gastric ulcers which is consider to be a most common gastrointestinal disorder. The main objective of this research was to evaluate the effects of avocado seeds aqueous extract as an adjunct to conventional ulcer treatment.
Methods: A randomized controlled trial was conducted with the participation of 99 patients diagnosed with gastric ulcers. Participants were randomly divided to a control group receiving standard medication and interventional group receiving the same treatment with avocado seeds aqueous extract. Screening and follow-up assessments assessment was performed by barium meal tests, radiological imaging, and serological markers, including H. pylori IgG and IgM (ELISA).
Results: Patients in the intervention group showed significant improvements in ulcer morphology and a marked reduction in H. pylori IgG and IgM levels compared with the control group (p < 0.05). Radiological findings also confirmed better mucosal healing in the supplemented group after 12 weeks of intervention.
Conclusions: Intervention group with avocado seeds aqueous extract showed a positive effect combined with conventional treatment, suggesting its potential as a natural adjunct therapy in management of gastric ulcers.
{"title":"Characterization of avocado seeds aqueous extract and its therapeutic effects on gastric ulcer.","authors":"Aroosa Sultan, Muhammad Nadeem Akhtar, Anees Ahmed Khalil, Faiza Jameel, Suhas Ballal, Abhayveer Singh, Rajashree Panigrahi, Abhishek Sharma, Huda Ateeq, Areesha Ahmed, Fakhar Islam, Muhammad Afzaal, Catherine Tamale Ndagire","doi":"10.1186/s12986-026-01080-w","DOIUrl":"https://doi.org/10.1186/s12986-026-01080-w","url":null,"abstract":"<p><strong>Background: </strong>Helicobacter pylori infection and oxidative stress are most common factors for development of gastric ulcers which is consider to be a most common gastrointestinal disorder. The main objective of this research was to evaluate the effects of avocado seeds aqueous extract as an adjunct to conventional ulcer treatment.</p><p><strong>Methods: </strong>A randomized controlled trial was conducted with the participation of 99 patients diagnosed with gastric ulcers. Participants were randomly divided to a control group receiving standard medication and interventional group receiving the same treatment with avocado seeds aqueous extract. Screening and follow-up assessments assessment was performed by barium meal tests, radiological imaging, and serological markers, including H. pylori IgG and IgM (ELISA).</p><p><strong>Results: </strong>Patients in the intervention group showed significant improvements in ulcer morphology and a marked reduction in H. pylori IgG and IgM levels compared with the control group (p < 0.05). Radiological findings also confirmed better mucosal healing in the supplemented group after 12 weeks of intervention.</p><p><strong>Conclusions: </strong>Intervention group with avocado seeds aqueous extract showed a positive effect combined with conventional treatment, suggesting its potential as a natural adjunct therapy in management of gastric ulcers.</p>","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145990018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-14DOI: 10.1186/s12986-026-01078-4
Faiyaz Ahmed, Bandar Moteb Almutairi, Saud Sulaiman Alharbi
{"title":"Impact of smartwatch data analytics on dietary consumption awareness among college students in Ar Rass, Al Qassim Region.","authors":"Faiyaz Ahmed, Bandar Moteb Almutairi, Saud Sulaiman Alharbi","doi":"10.1186/s12986-026-01078-4","DOIUrl":"https://doi.org/10.1186/s12986-026-01078-4","url":null,"abstract":"","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-13DOI: 10.1186/s12986-025-01073-1
Ting Xu, Yingqi Yang, Rong Xia, Jiahao Shen, Xiang Qi, Quan Wang, Zheng Zhu, Xichenhui Qiu, Qin Xu, Minghui Ji, Bei Wu
{"title":"Exploring gut microbiota mechanisms in frailty induced by 5-hydroxymethylfurfural: evidence from mouse models and Mendelian randomization.","authors":"Ting Xu, Yingqi Yang, Rong Xia, Jiahao Shen, Xiang Qi, Quan Wang, Zheng Zhu, Xichenhui Qiu, Qin Xu, Minghui Ji, Bei Wu","doi":"10.1186/s12986-025-01073-1","DOIUrl":"10.1186/s12986-025-01073-1","url":null,"abstract":"","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":" ","pages":"23"},"PeriodicalIF":4.1,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145966248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-11DOI: 10.1186/s12986-026-01079-3
Kaiya Xie, Yuqing Zhang, Lucas Ji Zong Yu, Xin Yu, Jiangbo He, Yingzhen Su
{"title":"Effects of Japan tallow on gut microbiota in type 2 diabetic mice.","authors":"Kaiya Xie, Yuqing Zhang, Lucas Ji Zong Yu, Xin Yu, Jiangbo He, Yingzhen Su","doi":"10.1186/s12986-026-01079-3","DOIUrl":"10.1186/s12986-026-01079-3","url":null,"abstract":"","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":" ","pages":"19"},"PeriodicalIF":4.1,"publicationDate":"2026-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12879351/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145952690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The association between life's crucial 9 and osteoarthritis in US adults: the mediating role of central adiposity.","authors":"Feng Luo, Jia-Jie Guo, Fu-Zhen Jiang, Xue-Mei Yuan, Heng Zhou, Qiu-Yi Wang, Chang-Ming Chen, Xue-Ming Yao, Wu-Kai Ma","doi":"10.1186/s12986-026-01082-8","DOIUrl":"10.1186/s12986-026-01082-8","url":null,"abstract":"","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":" ","pages":"22"},"PeriodicalIF":4.1,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12882590/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145945327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-09DOI: 10.1186/s12986-026-01074-8
Qingqing Zhang, Di Wu, Fengyun Guo, Shengnan Yang, Lijing Bao, Ruiying Zhang, Ping Wang
Background: Dietary fiber is inversely associated with metabolic syndrome (MetS); however, the mechanistic pathways and the consistency of this association across key demographic strata remain quantitatively unclear, which hinders the development of precise public health guidance.
Methods: This cross-sectional study included 7703 U.S. adults from the National Health and Nutrition Examination Survey (NHANES, 2010-2020). We employed survey-weighted logistic regression to assess the association between dietary fiber density (g/1000 kcal) and MetS (defined by NCEP-ATP III criteria). Mediation analysis was conducted to decompose the total association into pathways operating through systemic inflammation (log-transformed high-sensitivity C-reactive protein [hs-CRP]) and insulin resistance (HOMA-IR). We further evaluated effect modification by body mass index (BMI) categories.
Results: Each 1 g/1000 kcal increase in dietary fiber density was associated with a 4% reduction in the odds of MetS (OR = 0.96, 95% CI: 0.94-0.99). This inverse association was partially mediated by lower hs-CRP levels (proportion mediated: 7.4%, P = 0.023), with sensitivity analyses confirming robustness to additional lifestyle adjustments. The association was consistent across all BMI categories (interaction P > 0.62), suggesting homogeneous associations for normal-weight, overweight, and obese individuals.
Conclusions: In a nationally representative sample of U.S. adults, higher dietary fiber density is associated with a lower risk of metabolic syndrome. This association is partly explained by lower levels of systemic inflammation rather than by improvements in insulin resistance, and it is uniformly present across body weight statuses. These findings support the potential universal relevance of increasing fiber intake for MetS prevention and highlight anti-inflammatory pathways as a key area for mechanistic focus.
{"title":"Dietary fiber and metabolic syndrome in NHANES: mediation through inflammation and modifications by population characteristics.","authors":"Qingqing Zhang, Di Wu, Fengyun Guo, Shengnan Yang, Lijing Bao, Ruiying Zhang, Ping Wang","doi":"10.1186/s12986-026-01074-8","DOIUrl":"10.1186/s12986-026-01074-8","url":null,"abstract":"<p><strong>Background: </strong>Dietary fiber is inversely associated with metabolic syndrome (MetS); however, the mechanistic pathways and the consistency of this association across key demographic strata remain quantitatively unclear, which hinders the development of precise public health guidance.</p><p><strong>Methods: </strong>This cross-sectional study included 7703 U.S. adults from the National Health and Nutrition Examination Survey (NHANES, 2010-2020). We employed survey-weighted logistic regression to assess the association between dietary fiber density (g/1000 kcal) and MetS (defined by NCEP-ATP III criteria). Mediation analysis was conducted to decompose the total association into pathways operating through systemic inflammation (log-transformed high-sensitivity C-reactive protein [hs-CRP]) and insulin resistance (HOMA-IR). We further evaluated effect modification by body mass index (BMI) categories.</p><p><strong>Results: </strong>Each 1 g/1000 kcal increase in dietary fiber density was associated with a 4% reduction in the odds of MetS (OR = 0.96, 95% CI: 0.94-0.99). This inverse association was partially mediated by lower hs-CRP levels (proportion mediated: 7.4%, P = 0.023), with sensitivity analyses confirming robustness to additional lifestyle adjustments. The association was consistent across all BMI categories (interaction P > 0.62), suggesting homogeneous associations for normal-weight, overweight, and obese individuals.</p><p><strong>Conclusions: </strong>In a nationally representative sample of U.S. adults, higher dietary fiber density is associated with a lower risk of metabolic syndrome. This association is partly explained by lower levels of systemic inflammation rather than by improvements in insulin resistance, and it is uniformly present across body weight statuses. These findings support the potential universal relevance of increasing fiber intake for MetS prevention and highlight anti-inflammatory pathways as a key area for mechanistic focus.</p>","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":" ","pages":"21"},"PeriodicalIF":4.1,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12882584/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145945324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-08DOI: 10.1186/s12986-025-01072-2
Qing Zhang, Tao Ye, Xiaolin Zhou, Bolin Li, Zhen Zhang
{"title":"Circadian disruption is associated with advanced cardio-kidney-metabolic syndrome in overweight and obese adults: evidence from the NHANES database.","authors":"Qing Zhang, Tao Ye, Xiaolin Zhou, Bolin Li, Zhen Zhang","doi":"10.1186/s12986-025-01072-2","DOIUrl":"10.1186/s12986-025-01072-2","url":null,"abstract":"","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":" ","pages":"20"},"PeriodicalIF":4.1,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12882222/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145934502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Sex hormones are critical health determinants in both sexes. Some studies have found the association between sex hormones and all-cause mortality. However, the evidence of these association is limited and there is a lack of comprehensive investigation of various sex hormones.
Methods: Our study included a total of 7,294 participants from the 2013 to 2016 National Health and Nutrition Examination Survey (NHANES). The total testosterone (TT), estradiol (E2), and sex hormone-binding globulin (SHBG) levels were obtained from laboratory data, free testosterone (FT), free estradiol (FE2), free androgen index (FAI) and the ratio of TT to E2 (TT/E2) were calculated. Cox proportional hazards regression models and restricted cubic spline were used to analysis the association between various sex hormones and all-cause mortality, and stratified analyses according to age, sex, race, and history of diabetes and hypertension were performed.
Results: The final study sample included 3,473 male and 3,821 female from the NHANES. In the multivariate-adjusted model, male participants with higher FT and higher FAI had an obvious lower incidence of all-cause mortality [FT: HR, 0.41 (95% CI, 0.36-0.79); FAI: HR, 0.34 (95% CI, 0.25-0.92)], but these associations were not significant in female. And there was a positive correlation between SHBG concentration and mortality rate in both male and female participants, but the HR in males was higher than that in females [2.45 (95% CI, 1.69-6.23) vs 1.81 (95% 1.53-3.21)].
Conclusion: Our study found sex differences in the association of sex hormones and their related indicators with all-cause mortality, providing new insights for future research in this field.
{"title":"Sex difference of the associations of sex hormone and their related indicators with all-cause mortality.","authors":"Yu Sun, Meng Zhang, Mengying Niu, Xiaofei Zhang, Zhi Mao, Chang He, Shiyin Ma, Chucheng Jiao, Jiahao Chen, Xudong Pan, Xiaoyan Zhu","doi":"10.1186/s12986-025-01071-3","DOIUrl":"10.1186/s12986-025-01071-3","url":null,"abstract":"<p><strong>Background: </strong>Sex hormones are critical health determinants in both sexes. Some studies have found the association between sex hormones and all-cause mortality. However, the evidence of these association is limited and there is a lack of comprehensive investigation of various sex hormones.</p><p><strong>Methods: </strong>Our study included a total of 7,294 participants from the 2013 to 2016 National Health and Nutrition Examination Survey (NHANES). The total testosterone (TT), estradiol (E2), and sex hormone-binding globulin (SHBG) levels were obtained from laboratory data, free testosterone (FT), free estradiol (FE2), free androgen index (FAI) and the ratio of TT to E2 (TT/E2) were calculated. Cox proportional hazards regression models and restricted cubic spline were used to analysis the association between various sex hormones and all-cause mortality, and stratified analyses according to age, sex, race, and history of diabetes and hypertension were performed.</p><p><strong>Results: </strong>The final study sample included 3,473 male and 3,821 female from the NHANES. In the multivariate-adjusted model, male participants with higher FT and higher FAI had an obvious lower incidence of all-cause mortality [FT: HR, 0.41 (95% CI, 0.36-0.79); FAI: HR, 0.34 (95% CI, 0.25-0.92)], but these associations were not significant in female. And there was a positive correlation between SHBG concentration and mortality rate in both male and female participants, but the HR in males was higher than that in females [2.45 (95% CI, 1.69-6.23) vs 1.81 (95% 1.53-3.21)].</p><p><strong>Conclusion: </strong>Our study found sex differences in the association of sex hormones and their related indicators with all-cause mortality, providing new insights for future research in this field.</p>","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":" ","pages":"12"},"PeriodicalIF":4.1,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12829098/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145917849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}